The links just keep coming, dear readers!
Continue reading “Unrequired Reading: Aug. 24, 2007”

A podcast about books, art & life — not necessarily in that order
Sure, I get plenty of headaches at work, but there’s also fun to be had. You just have to know where to look. For instance, while checking out news releases this morning, I stumbled across a clinical-stage drug that’s described as a “minor groove binder.”
I’m in my mid-30s and have a family history of high blood pressure, diabetes and heart disease, so I figure it’s best that I start getting some expert opinion on my health. I’m not diligent enough to see a doctor regularly, but I did manage to have my nowhere-near-annual physical this morning.
I had to fill out a general medical info form when I got to the office. Near the top of the form was a line for ‘Chief complaint,’ which I responded to with “high taxes.” I know I should’ve gone with “incivility on the internet,” but that’s what you get for writing in ink.
Anyway, the doctor was happy with pretty much everydarnthing. My LDL’s a little high, but it’s down 30 points from my last checkup in September 2005, so no statins for me! Blood pressure, heart-rate and EKG were also just fine. He even praised my moderate drinking, though he admitted that there wasn’t a ton of research on the benefits of gin.
I was actually a little worried about that EKG, given a family member’s recent episode of SVT, but the doctor assuaged my fears on that one. He mentioned that the EKG showed no basic signs of it and, “When you hit 50, we’ll do a stress test and all the other regular exams.”
“When I’m 50,” I said, “we’ll have nanobots to take care of that stuff.”
Then I thought, I’m gonna be 50?
The dog days of summer require extra-entertaining links, just to raise us from our doldrums! Good thing I have a bunch for you, dear readers!
Continue reading “Unrequired Reading: Aug. 10, 2007”
This NYTimes article provides the most detailed account of a firing I’ve ever read in a paper. Warren J. Spector at Bear Stearns got the boot because his unit controlled the hedge funds that imploded a few weeks back. The first hint that it’s a weird article is the description of the firing:
Sitting behind his half moon desk on which stood computer terminals and a large metal-box lighter, Mr. Cayne broke the news to Mr. Spector that he wanted his resignation.
Seemed like a little more info than we needed. Then it began exploring the two men’s history with the game of bridge:
Indeed, with Mr. Spector’s own talent for bridge — he achieved the rank of life master at age 16 in 1974 — and his expertise in all varieties of bonds, it was widely assumed that Mr. Cayne would pass on the reins to Mr. Spector. (The two men’s devotion to bridge is highlighted by the fact that they both attended the North American bridge championship in Nashville late last July, at a time of increasing turmoil in the credit markets.)
But while bridge might have functioned as a bonding agent between Mr. Cayne and his predecessor, Alan C. Greenberg, it could not do the same for Mr. Spector — especially in the wake of the hedge fund meltdown at the firm’s asset management division.
Did I mention there’s too much detail?
In part this was a function of their sharply different personalities. Mr. Cayne is a raw, cigar-chomping man who embraces the scrappy, street-fighting ethos of the firm. Mr. Spector, who wears his thick head of hair longer than that of the standard banker, has more of suave, relaxed affect.
I guess the big question is: which guy’s the better bridge partner?
(Update: The WSJ article on Spector’s firing adds even more details, including the facts that he “wears black-rimmed glasses and maintains a trim physique”. . . and that he attended St. John’s College, where I got my master’s degree)
Work is under control: the July/August issue landed on my desk yesterday, the Top Companies report’s website is live, our conference enrollment is rolling along, and our September issue looks like it’ll be a big one. So I’m taking a vacation day!
I’m heading down to Philly to visit a friend of mine (Drake, not Butch) for a while. No worries, dear readers: I’ll have my camera with me and will likely end up somewhere where I can take some neat pix. Maybe I’ll meander downtown in Philly or visit the suburbs near Swarthmore where I used to live. Or I could stop in Princeton on the way home and stop in at the campus art museum (and the Record Exchange, of course).
The good news? Amazon’s net profit more than tripled.
The bad news? The WSJ broke out the Drew Friedman-izer on Jeff Bezos:

Tim Hortons is the dark horse, but that’s where I’d put my money in this fight.
Aiee! It’s a Friday the 13th edition of Unrequired Reading! Hockeymask-wearing, knife-wielding links coming up!
Continue reading “Unrequired Reading: July 13, 2007”
Today’s WSJ has an interview with GlaxoSmithKline CEO Jean-Pierre Garnier. While the bulk of the interview covers the company’s Avandia crisis, JP also kicks some wisdom regarding the “developing world”:
WSJ: Glaxo recently donated 50 million pandemic flu vaccines to the World Heath Organization. What’s the story?
Dr. Garnier: It’s probably the largest vaccine donation ever. The company could have sold possibly those 50 million units. They [Glaxo] decided to set them aside because frankly those countries are not going to buy any pandemic vaccine. Some of them have no commitment to health care.
Let’s call a cat a cat. They’ll buy a lot of other things including Kalashnikovs before they allocate enough money for health care in their own countries.